PTH and brain cancer: Higher PTH associated with inferior EFS in primary malignant brain tumors [HR, 1.80 (1.19–2.72)], embryonal malignancies [HR, 2.20 (1.1–4.43)], and lymphatic malignancies [HR 1.98 (1.05–3.72)].